LOGO
LOGO

Biotech Daily Dose

SBC Medical Prices Secondary Offering Of 3.1 Million Shares

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us

SBC Medical Group Holdings Incorporated (SBC) announced the pricing of a secondary public offering of 3.1 million shares of common stock by Dr. Yoshiyuki Aikawa, the company's founder and selling stockholder. The shares were priced at $3.25 per share, with underwriters granted a 45-day option to purchase up to an additional 465,000 shares.

The offering is expected to close on or about April 21, 2026, subject to customary conditions. Importantly, SBC Medical itself is not selling any shares in this offering, and all proceeds will go directly to the selling stockholder.

Maxim Group LLC is acting as the sole book-running manager, with Roth Capital Partners serving as co-manager. The offering is being conducted under SBC Medical's effective shelf registration statement on Form S-3 filed with the U.S. Securities and Exchange Commission.

SBC Medical Group Holdings operates a broad portfolio of franchise businesses across diverse medical fields, including aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, alopecia treatment (AGA), and ophthalmology. The company has expanded its global presence through direct operations and medical tourism initiatives, with a growing footprint in the United States and Asia.

Listed on Nasdaq in September 2024 and added to the Russell 3000 Index in June 2025, SBC Medical continues to pursue its stated purpose of "contributing to the well-being of people around the world through medical innovation."

SBC has traded between $2.97 and $5.75 over the past year. The stock closed Friday's trading (April 17, 2026) at $4.49, up 1.58%.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update -May 18 – May 22, 2026

May 22, 2026 14:46 ET
Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.

RELATED NEWS
Latest Updates on COVID-19